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Ruptured or Intact Fibrous Caps*
Eloisa Arbustini, MD,y Nupoor Narula, MD,yz Takahide Kodama, MDyxPRE-PCI, OCT-BASED CHARACTERIZATION
OF CULPRIT PLAQUES IN STEMII n vivo intravascular imaging of culprit plaques inacute coronary syndrome (ACS) may shed light onthe plaque substrate of acute thrombosis, either a
ruptured ﬁbrous cap (RFC) or an intact ﬁbrous cap
(IFC). This may help to unravel mechanisms of acute
coronary thrombosis in ACS, monitor plaque healing
after an acute event, and revisit indications for inter-
ventional treatments, in particular, stenting.
The OCTAVIA (Optical Coherence Tomography
Assessment of Gender Diversity in Primary Angio-
plasty) study is an interventional phase 4 trial that
enrolled 140 ST-segment elevation myocardial infarc-
tion (STEMI) patients (70 male and 70 female) ac-
cording to pre-deﬁned criteria. Patients with STEMI
underwent quantitative coronary angiography,
thrombus aspiration, post-aspiration optical coher-
ence tomography (OCT) to investigate the morphology
of the culprit plaque, everolimus-eluting stenting of
the culprit lesion (independent of the culprit plaque
morphology), post-stenting OCT, and further quanti-
tative angiography in the short- and long-term
follow-up. The primary outcome measures were the
percentage of RFCs and IFCs at the infarct-related
lesion and the assessment of sex differences as
assessed by OCT. The coprimary endpoint was the
evaluation of the percentage of covered stent struts by
OCT in the infarct-related lesion at 9 months in RFC
lesions and IFC lesions 9 months after treatment.*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
From the yCenter for Inherited Cardiovascular Diseases, IRCCS
Foundation Policlinico San Matteo, Pavia, Italy; zDepartment of Internal
Medicine, Mayo Clinic, Rochester, Minnesota; and the xCardiovascular
Center, Toranomon Hospital, Tokyo, Japan. The authors have reported
that they have no relationships relevant to the contents of this paper to
disclose. Dr. Jagat Narula was not involved in the editorial handling of
this manuscript.Further aims were the comparative evaluation of bio-
markers in RFCs versus IFCs and the analysis of the
aspirated material.
OCT CONFIRMS THE PREVALENCE OF
DIFFERENT PLAQUE SUBSTRATES
TRIGGERING ACUTE THROMBOSIS IN AMI
Autopsy studies have shown that acute myocardial
infarction (AMI) is caused by the acute thrombotic
occlusion of an epicardial coronary artery (1); coro-
nary dissections may cause AMI in a minority of cases
(2). Acute coronary thrombosis occurs with coronary
plaque rupture in w75% of AMI and plaque erosion in
the remaining 25% (3). These proportions are some-
what similar in AMI and sudden coronary death (4).
In vivo intracoronary OCT-based imaging has
conﬁrmed the proportion of both rupture and erosion
described in autopsy series (5,6). Such clinical imag-
ing studies have validated the pathological ﬁndings
and have contributed to the characterization of
vulnerable plaques prone to rupture, including su-
perﬁcial plaque inﬂammation (7) and erosion in which
the pathological substrate increases local thrombo-
genic potential (8). Other ﬁndings, including super-
ﬁcial calciﬁc nodules as substrates of acute coronary
thrombosis in AMI (9,10) and a higher prevalence of
plaque erosion in females than in males (3,4), have
not been conﬁrmed in vivo.
Pathological diagnosis of cap rupture describes a
plaque characterized by a thin-cap ﬁbroatheroma
with loss of continuity of the cap, whereas erosion
describes a condition in which the thrombus forms on
either a ﬁbrous plaque or a ﬁbroatheroma with a thick
cap. The OCT diagnosis of plaque rupture and erosion
in an acute event reproduces the pathological ﬁnd-
ings and is based on the evidence of thrombus
occurring on a ruptured ﬁbrous cap and an empty
core cavity versus preserved ﬁbrous cap integrity in
an acute event with an intact ﬁbrous cap, respectively
(11). In the OCTAVIA study, although plaque rupture
and erosion are structurally different, the ﬁnal effect
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577appears to be similar, making treatment the same,
even though the underlying mechanisms of platelet
adherence and thrombus generation may be different
(12,13).
THE OCTAVIA TRIAL RESULTS IN STEMI
The primary outcome measures and related results
reported by Saia et al. (14) in this issue of iJACC are
part of the OCTAVIA trial and demonstrated that: 1) an
IFC was the plaque substrate for acute coronary
thrombosis in approximately one-third of cases; 2) as
assessed by OCT, the prevalence of IFCs was similar in
male and female patients, not conﬁrming the higher
prevalence of IFCs noted in females in the autopsy
studies; 3) there was no difference in the extent of
covered stent struts by OCT in infarct-related lesionsSEE PAGE 566at 9 months regardless of the plaque substrate, either
RFC or IFC; and 4) the morphology of the culprit
plaque was not associated with any speciﬁc clinical
features or biological markers. The levels of high-
sensitivity C-reactive protein, eosinophil cationic
protein, thromboxane B2, and myeloperoxidase were
similar, and the immunohistochemical study of aspi-
rated material obtained from RFC and IFC substrate
showed similar myeloperoxidase- and CD68-positive
cells, as well as a similar CD42b score.
CLINICAL IMPLICATIONS OF THE STUDY
The observation that acute and chronic vascular
response to percutaneous coronary intervention (PCI)FIGURE 1 Samples of Aspirated Material From Atherosclerotic Plaq
(A) A sample that has been immunostained with anti-CD68 antibodies.
clefts, which are undoubtedly originating from a ruptured ﬁbro-fatty pl
aspirated in the culprit lesion of a patient with acute myocardial infarctio
undoubtedly originates from a ruptured core-rich plaque.with current generation of everolimus-eluting stents
happened to be similar in patients with IFCs and RFCs
seems to indicate a limited clinical role for pre-
interventional characterization of the plaque sub-
strate in ACS. However, this ﬁnding has been a matter
of controversy, as in the past few years, emerging
OCT-based studies (5,15) highlighted the possibility of
stenting RFC plaques and not stenting IFC plaques
while maintaining aggressive antiplatelet treatment
after manual thrombus aspiration or thrombolysis-
mediated dissolution. The local healing response to
PCI, similar for both RFC and IFC plaques in the
OCTAVIA study (14), may be explained either by
heavy platelet inhibition that provides protection
against any ACS plaque morphology where platelets
are involved or the fact that stents produce the same
local healing response in coronary arteries, which
may be independent of the local pathology. Similar
morphology of local healing does not necessarily
equate to identical treatment. Is it also possible that
knowing local plaque characteristics before the
intervention may beneﬁt IFCs with a tight lesion and
may predict embolic rates and slow ﬂow in RFCs?
Additionally, the observation that 75% of IFC pla-
ques versus 100% of RFC plaques were lipid rich may
suggest a better imaging-based deﬁnition of a pulta-
ceous core in plaques with IFC, where hemorrhagic
invasion of the core did not occur. An important
ﬁnding of the study (14) is the characterization of
plaque material in the RFC (23 of 42, 54.8%)
compared with the IFC (1 of 13, 7.7%). Aspiration of
the material occluding the coronary lumen at the
culprit site in plaques with RFCs may extract capues in AMI Patients
The sample contains foamy macrophages (brown) and cholesterol
aque. (B) A MOVAT pentachrome–stained sample from the material
n. The sample shows pultaceous cholesterol cleft-rich material, which
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578fragments and/or necrotic core debris (Figure 1). The
post-aspiration OCT images reveal empty cores
delimited by the ﬁbrous strands of the residual cap
and by the empty crater of the plaque core; the
ruptured ﬁbrous cap OCT panel of Figure 1 in Saia et
al. (14) shows a typical view of an empty core in a
ruptured plaque. OCT studies have contributed to
unraveling the mechanisms of plaque healing after
dissolution of the acute thrombus with and with-
out stent implantation (5,15). Although in RFCs, the
thrombogenic collagen substrate of the internal
layers of the ﬁbrous capsule may remain exposed
even after aspiration, the risk of recurrent thrombotic
events is likely prevented by the antiplatelet treat-
ment that staves off thrombosis during the healing
and re-endothelialization phase. The study by Saia
et al. (14) found plaque material, similar to samples
from RFCs, from only 1 IFC event, thus indicating thateither the aspiration procedure itself ruptured an
intact cap or OCT did not correctly recognize an RFC.
Numerous imaging studies, including the present
one, are providing evidence of the feasibility of
in vivo pre-PCI intravascular diagnostics and post-
procedural monitoring of the treatments of the
culprit plaque in ACS. Solutions other than stenting
could be matter of consideration when treating pla-
ques that show low structural vulnerability, such as
those with IFCs, high Thrombolysis In Myocardial
Infarction ﬂow grade and small plaque burden after
effective thrombus aspiration.
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